Blueprint Medicines Corp (BPMC)

$91.65 2.09 (2.23%)

16:00 EDT BPMC Stock Quote Delayed 30 Minutes

5 Biotech Stocks to Buy for a Strong Growth Prognosis

By Aaron Levitt, InvestorPlace Contributor Mar 11, 2020

The long-term outlook is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.

Avis Budget Group Inc. (CAR) Leads 8 Notable Investor Filings

Volume:

Previous Close -

Market Cap 5.35B

PE Ratio 16.51

EPS 5.55

Volume (Avg. Vol.) 352,786

Day's Range 91.63 - 94.25

52-Week Range 60.00 - 125.61

Dividend & Yield N/A (N/A)

BPMC Stock Predictions, Articles, and Blueprint Medicines Corp News

From the Web

Technical Short Put Spread Fade the Dip Trade and Trigger in Blueprint Medicines Corp

From Capital Market Laboratories May 11, 2021

The Techncial Trigger Driven Option Trade Right Before Blueprint Medicines Corp (NASDAQ:BPMC) Earnings.

BPMC Crosses Above Key Moving Average Level

From Market News Video May 7, 2021

In trading on Friday, shares of Blueprint Medicines Corp (BPMC) crossed above their 200 day moving average of $95.25, changing hands as high as $95.88 per share. Blueprint Medicines Corp shares are currently trading up about 1.9% on the day..

Recap: Blueprint Medicines Q1 Earnings

From Benzinga Apr 29, 2021

Shares of Blueprint Medicines (NASDAQ:BPMC) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share were up 18.48% over the past...

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx

From Benzinga Apr 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

First Week of June 18th Options Trading For Blueprint Medicines (BPMC)

From Market News Video Apr 21, 2021

Investors in Blueprint Medicines Corp (BPMC) saw new options become available this week, for the June 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BPMC options chain for the new June 18th contracts and identified one put and one call contract of particular interest.

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx

From Benzinga Apr 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...